Crisantaspase

5 trials 1 recruiting LOncology

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

1 Recruiting

4 Completed trials

5 Sponsors

20 Countries

Phase III

Phase II

Phase III: 4 Phase II: 1

Oversight events:

2 serious breaches 1 corrective measure across 3 trials

View oversight register →

Sponsors using this IMP

Amgen Inc. 1 Medical University Of Silesia Katowice Poland 1 Pfizer Inc. 1 Universita Degli Studi Di Milano Bicocca 1 Universitaetsklinikum Schleswig-Holstein 1

All trials

5 total

A Ph2 Superiority Study with InO Monotherapy vs ALLR3 for Induction Treatment of Childhood HR ALL Recruiting

2023-509810-13-00 Phase II 16 countries Pfizer Inc.
A Randomized Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults … Ended

2023-503640-14-00 Phase III 17 countries Amgen Inc.
AIEOP-BFM 2017 POLAND - Collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia - A randomized phas… Ended

2024-517253-27-00 Phase III 1 country Medical University Of Silesia Katowice Poland
AIEOP-BFM ALL 2017 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia Ended

2023-509856-32-00 Phase III 5 countries Universitaetsklinikum Schleswig-Holstein
International trial in Philadelphia chromosome-positive acute lymphoblastic leukemia Ended

2024-515499-12-00 Phase III 12 countries Universita Degli Studi Di Milano Bicocca

Showing 1–5 of 5 trials

← All drugs A–Z